Lung Cancer Research
Why We Need Research
Research provides hope and save lives. This is especially true when it comes to lung cancer research. Lung cancer research can help develop better treatments, increasing the survival and quality of life for patients. Research can provide a better and longer future for those diagnosed with lung cancer as well and can also ultimately increase the number of survivors living with the disease.
The Lung Association supports lung cancer research so we can help prevent lung cancer cases, and failing that, prolong the lives of lung cancer patients. We have made some progress, but we plan to invest more, as lung cancer remains the leading cause of cancer deaths in the United States.
Our Lung Cancer Research Program
The American Lung Association is committed to funding lung cancer research. As part of our Awards and Grants Program, a large part of funds go toward research on lung cancer prevention, treatment and quality of life. The primary goal of this lung cancer research program is simple: improve and save lives. The secondary goal is almost as important: To fund top-notch lung cancer researchers at important career crossroads to and gain long-term commitment to lung cancer research. Without the life-long dedication of lung cancer researchers and a large and active community of people trying to improve patients' lives, important and much needed discoveries would be impossible.
What Research Is Being Done?
Thanks to the medical breakthroughs led by Lung Association researchers and their colleagues worldwide, our lung cancer researchers have made significant contributions to the field of lung cancer. For example, tumor testing and targeted therapies have helped advance the area of personalized treatment (finding the unique genetic makeup of a person's tumor and developing and using drugs that are designed to be most effective for that patient).
In 2016-2017, Lung Association researchers are studying things like:
- How lung cancer tumors become resistant to drug therapy and how to stop the process.
- New techniques, such as using mutant cancer genes against the tumor's own growth.
- Using new formulations of treatment that may better target lung tumor cells.
- Whether the effectiveness of CT screening for lung cancer seen in a national trial translates into real-world benefits in everyday medical practice.
- Research that could determine if radiation during heart procedures causes women to have a greater chance of developing lung cancer compared to men.
- A targeted therapy that could lead to treatment that would stop the spread of lung adenocarcinoma.
Lung Cancer Researchers
Below are some of our lung cancer researchers and their studies. Learn more about our current lung cancer research studies at Research Awards Nationwide.
- Elnaz Atabakhsh, PhDGene Mutation Makes Lung Cancer Less Responsive to Treatment
- Ankit Bharat, MDThe Role of Carbon Dioxide in Stopping Lung Healing After Lung Cancer Surgery
- Melanie Blevins, PhDInhibiting the Formation of a Protein Complex to Treat Lung Cancer
- Timothy Burns, MD, PhDDetermining How Two Genes Interact in Lung Cancer
- Emily Cheng, MD, PhDOvercoming Resistance to Newest EGFR-Inhibiting Lung Cancer Drugs
- Chen-Hua Chuang, PhDMolecular Biography of Lung Cancer Metastasis
- Eric Collisson, MDUsing Genomics to Attack Lung Cancer
- Kristina Crothers, MDImproving How We Implement Lung Cancer Screening in Diverse Patient Populations
- Tushar Desai, MD, MPHGenetic Tools Help Shed Light on Lung Cancer Progression
- Joyita Dutta, PhDUsing PET/MRI Images in Late-Stage Lung Cancer Treatment
- Anthony Faber, PhDResensitizing Cells to Lung Cancer Targeted Therapy
- David Feldser, PhDTargeting Molecular Pathway Could Lead to Lung Adenocarcinoma Treatment
- Mark Fuster, MDDisrupting Complex Sugars on Immune Cells Could Inhibit Growth of Lung Cancer
- Sharad Goyal, MDDoes Radiation From Heart Procedures Increase Risk of Lung Cancer?
- Lida Hariri, MDDoes Tumor Environment Promote Drug Resistance in Lung Cancer Cells?
- Khaled Hassan, MDOvercoming Resistance to Lung Cancer Drugs
- Landon Inge, PhDCompound Could Help Some Patients With Non-Small Cell Lung Cancer
- Humam Kadara, PhDChanges in Airway Could Signal Early Lung Cancer Development
- Peter Kaiser, PhDDrugs to Reactivate Tumor-Killing Ability of p53
- Jung-whan Kim, PhDProtein May Hold Key to New Treatments for Squamous Cell Lung Cancer
- Ji Yeon Kim, PhDLung Cancer Mutations Increase Levels of Polyamines
- John Koomen, PhDTargeting Kinases in Lung Cancer Treatment
- Wenyu Liu, PhDPreventing Lung Cancer Stem Cells From Self-Renewinglung cancer, new jersey
- Yutaka Maeda, DVM, PhDEradicating Every Last Lung Cancer Cell
- Nancy McNamara, OD, PhDInhibiting a Protein Might Help Prevent or Treat Lung Cancer
- Michelle Mendoza, PhDStopping Lung Cancer Cell Invasion
- Sweta Mishra, PhDDiscovering Protein's Role in Resistance to Lung Cancer Chemotherapy
- John Poirier, PhDMolecular Mechanisms of Acquired Drug Resistance in Small Cell Lung Cancer
- Linda Resar, MDTherapy Blocks Protein Involved in Lung Cancer Growth
- Sameek Roychowdhury, PhD, MDIdentifying Gene Mutations in Lung Cancer That Can Be Attacked With Smart Drugs
- Shiladitya Sengupta, PhDUsing Nanoparticles to Improve Lung Cancer Treatment
- Brittany Sexton, PhDDiscovering Inner Workings of Enzyme Could Lead to Lung Cancer Treatment
- David Shackelford, PhDSelectively Targeting Metabolic Needs Unique to Lung Cancer
- Anurag Singh, PhDUnderstanding Role of Mutated KRAS Gene in Lung Cancer
- Samir Soneji, PhDDoes the Effectiveness of CT Screening Translate into Real-World Benefits?
- Srinivas Sridhar, PhDInjectable Lung Cancer Therapy with PARP Inhibitors Could Better Target Tumor Cells
- Eric Sweet-Cordero, MDExamining Cell-to-Cell Communication for Clues about Lung Cancer
- Seyedtaghi Takyar, MD, PhDEnhancing the Targeting of Tumor Blood Vessels in Lung Cancer
- Phuoc Tran, MD, PhDTargeting a Gene Involved in Lung Cancer Drug Resistance
- Linda Van Aelst, PhDSeeking Treatment to Stop Spread of Lung Adenocarcinoma
- Narendra Wajapeyee, PhDTargeting p53 Gene to Treat Lung Cancer
- Guanghu Wang, PhDFighting Drug Resistance in Lung Cancer
- Johnathan Whetstine, PhDEnzyme Could Help Predict Effectiveness of Lung Cancer Chemotherapy
- Henning Willers, MDAttacking Lung Cancer Before It Develops Drug Resistance
- Monte Winslow, PhDFactors in the Spread of Lung Cancer
- Gutian Xiao, PhDUsing Protein to Help Diagnose and Treat Lung Cancer
How You Can Be a Part of Research
Lung Cancer Registry
The Lung Cancer Registry is a database of medical information collected from thousands of lung cancer patients. Researchers study this health data to gain a better understanding of the disease, which can ultimately lead to better outcomes for patients. By participating in the Registry, you not only will help advance lung cancer research, but you will also be able to learn about new clinical trial opportunities that may help in your own treatment program.
Lung Cancer Clinical Trials
You can also search the Lung Cancer Clinical Trials Matching Service, provided by a partnership between the American Lung Association and EmergingMed. Patients can search for clinical trials that match their specific diagnosis and treatment history.
Find a Clinical Trial
Learn more about clinical trial programs in your area by searching our list and be sure to discuss with your doctor whether a clinical trial is right for you.
Approved by Scientific and Medical Editorial Review Panel. Last reviewed October 27, 2016.